20 preterm infants receive parenteral nutrition containing 20% MOFS lipid emulsion (Smoflipid ®)

20 preterm infants with sepsis receive the usual parenteral nutrition containing soybean oil based lipid emulsion (20% Intralipid ®) at daily increasing doses guided by serum triglycerides.

Sepsis Newborn

Smoflipid ®

Mansoura University Children Hospital

The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis

The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis: a Randomized Pilot Controlled Trial

changes in levels of sICAM-1 in septic preterm infants after receiving one of the two different lipid emulsions for seven days.

changes in leukocyte integrin ß2 level in septic preterm infants after receiving one of the two different lipid emulsions for seven days.

Effect of two different lipid emulsions on hospital stay duration in septic preterm infants

Effect of two different lipid emulsions on duration of antibiotics treatment in septic preterm infants

Effect of two different lipid emulsions on duration of mechanical ventilation in septic preterm infants

Effect of two different lipid emulsions on mortality rate in septic preterm infants

Yahya Wahba

Principal Investigator

Bacterial Vaginosis

Medical device (registration number: 10-355-717, first licensed 12.08.2010)

Vaginal lactic acid and glycogen gel

Metronidazole

Dep. of Obstetrics and Gynecology, Bern University Hospital, Bern

Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis

Controlled, Multicenter, Randomized Parallel Group Pilot Study With 2 Treatment Arms in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis (BV)

This is a binary parameter indicating remission from BV.

Unpleasant vaginal discharge, unpleasant smell, vaginal pain, itching, burning, dryness

University Hospital Inselspital, Berne

Tentan AG

Diverticulosis

Diverticulitis

Lactobacillus Reuterii 10000000000 CFU per day

Lactobacillus Reuterii

placebo

Careggi Hospital

Casa Sollievo della Sofferenza Hospital - IRCCS

Role Of Lactobacillus Reuteri DSM 17938 In The Non-Complicated Diverticular Disease

Phase 3 Study of Lactobacillus Reuterii in Patients With Symptomatic Non-complicated Diverticular Disease

A validated questionnaire was used to investigate on intestinal symptoms. The following symptoms/signs will be investigated:
Abdominal pain
Abdominal bloating
Urgency
Diarrhoea
Abdominal Tension
Each factor previously listed will be graded according to the following scale of gravity:
0= no symptom
1= light disturbance
2= moderate disturbance
3= serious disturbance The score of activities can range between 0 (asymptomatic patient) to 15 (serious disturbances with important impacts on the quality of life).

To value the efficancy in reduction of acute diverticulitis, defined as episodes of abdominal pain associated with fever and/or abdominal resistance, increment of ESR and neutrophil leucocitosis and that demand a treatment of systemic antibiotics

acetic acid/feber

The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis

Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis

Role Of Lactobacillus Reuteri DSM 17938 In The Non-Complicated Diverticular Disease

Den mest komplette database med medicinske urter understøttet af videnskab